L.S. Constine - Concepedia

Author

L.S. Constine

University of Rochester

Also Known As

L CONSTINE, L Constine, L S Constine, L. Constine, L. S. Constine, L.S Constine, L.S. Constine, LS Constine

Publications

666

Citations

H-Index

Concepts

All Affiliations

University of Rochester Washington University in St. Louis University of Rochester Medical Center

About

L.S. Constine is an author at University of Rochester specializing in medicine, cancer research, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	260
2	Health Sciences	3	3	148
3	Immunology	3	3	160
4	Pathology	2	2	100
5	Child Development	1	1	90

L.S. Constine

Publications

370

Citations

H-Index

Page 1

	Year	Citations
Influence of Age, Sex, and Concurrent Intrathecal Methotrexate Therapy on Intellectual Function after Cranial Irradiation During Childhood: A Report from the Children's Cancer Study Group W. Archie Bleyer, James A. Fallavollita, Leslie L. Robison, Pediatric Hematology and Oncology Cranial IrradiationHematological MalignancyRadiologyIntellectual FunctionRadiation Therapy	1990	90
Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34 Douglas Strother, Lucie Lafay‐Cousin, J. M. Boyett, Neuro-Oncology	2013	76
Autotransplantation for relapsed or refractory Hodgkin’s disease: long-term follow-up and analysis of prognostic factors J. E. Lancet, AP Rapoport, R.A. Brasacchio, Bone Marrow Transplantation Prognostic FactorsTransplantationDisease ProgressionImmunologyMedicine	1998	60
Autotransplantation for relapsed or refractory non-Hodgkin’s lymphoma (NHL): long-term follow-up and analysis of prognostic factors AP Rapoport, Richard P. Lifton, L.S. Constine, Bone Marrow Transplantation Prognostic FactorsLymphoid NeoplasiaTransplantationLong-term Follow-upMedicine	1997	52
Randomized phase III U.S./Canadian intergroup trial (SWOG S9704) comparing CHOP ± R for eight cycles to CHOP ± R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL). Pat Stiff, Joseph M. Unger, James R. Cook, Journal of Clinical Oncology Disease ProgressionImmunodeficienciesImmunologyTransplantation MedicinePathology	2011	48
Birth Defects in Three Common Pediatric Malignancies; Wilms’ Tumor, Neuroblastoma and Ewing’s Sarcoma N. Nakissa, L.S. Constine, P. Rubin, Oncology	1985	20
Late Effects of Radiation Therapy L.S. Constine SpringerReference	2012	14
Predictors of early response and event-free survival in Hodgkin lymphoma (HL): PET versus CT imaging. C. L. Schwartz, Debra A. Friedman, Kathleen M. McCarten, Journal of Clinical Oncology Early ResponseEarly CtOncologic ImagingPet-mriMultimodality	2011	10

Page 1